Figures & data
Table 1 Included Literature Listed by Year of Publication with Associated Study Size, NHMRC Level of Evidence and Grading
Mirinezshad S, Mousavi F, Baghri M, Sepehri B, Ghavidel A, Ghojazadeh M. Congenital hypertrophy of the retinal pigment epithelium for diagnosis of familial adenomatous polyposis – the first FAP registry in Iran. Asian Pac J Cancer Prev. 2018;19(1):167–169. Chen C, Phillips K, Grist S. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer. Fam Cancer. 2006;5(4):397–404. Tourino R, Conde-Freire R, Cabezas-Agricola J, et al. Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. Int Ophthalmol Clin. 2004;25(2):101–112. Rushwurm I, Zehetmayer M, Dejaco C, Wolf B, Karner-Hanusch J. Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis. Am J Ophthalmol. 1998;125(5):680–686. Gelisken O, Yucel A, Guler K, Zorluoglu A. Ocular findings in familial adenomatous polyposis. Int Ophthalmol. 1998;21(4):205–208. Lam D, Kwok S, Kwok A, Liew C, Lau J, Pang C. Incidence and predictive value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients. Chin Med J (Engl). 1998;111(3):278–281. Tiret A, Taiel-Sartral M, Tiret E, Laroche L. Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol. 1997;81(9):755–758. Traboulsi E, Apostolides J, Giardiello F, et al. Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis. Ophthalmic Genet. 1996;17(4):167–174. Rossato M, Rigotti M, Grazia M, Turco AE, Bonomi L. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and familial adenomatous polyposis (FAP). Acta Ophthalmol Scand. 1996;74(4):338–342. Olea J, Mateos J, Llompart A, Obrador A. Frequency of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Acta Ophthalmol Scand. 1996;74(1):48–50. Valanzano R, Cama A, Volpe R, et al. Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis; novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations. Cancer. 1996;78(1):2400–2410. Hunt L, Robinson M, Hugkulstone C, et al. Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer. Br J Cancer. 1994;70(1):173–176. Hodgson S, Bishop D, Jay B. Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis. J Med Genet. 1994;31(1):44–48. Campbell W, Spence R, Parks T. The role of congenital hypertrophy of the retinal pigment epithelium in screening for familial adenomatous polyposis. Int J Colorect Dis. 1994;9:191–196. Chagas C, Fidalgo P, Marins A, et al. Vale of congenital hypertrophy of the retinal pigment epithelium as diagnostic marker in familial adenomatous polyposis. Acta Med Port. 1993;6(7):303–306. Hickey-Dwyer M, Willoughby C. Assessment of the value of congenital hypertrophy of the retinal pigment epithelium as an ocular marker for familial adenomatous polyposis coli. Eye (Lond). 1993;7:562–564. Bertario L, Russo A, Sala P, et al. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol. 2003;21(9):1698–16707. Romania A, Zakov Z, Church J, Jagelman D. Retinal pigment epithelium lesions as a biomarker of disease in patients with familial adenomatous polyposis. A follow-up report. Ophthalmology. 1992;99(6):911–913. Morton D, Gibson J, Macdonald F, et al. Role of congenital hypertrophy of the retinal pigment epithelium in the predictive diagnosis of familial adenomatous polyposis. Br J Surg. 1992;79(7):689–693. Moore A, Maher E, Koch D, Charles S. Incidence and significance of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial adenomatous polyposis coli (FAPC). Ophthalmic Paediatr Genet. 1992;13(6):67–71. Giardiello F, Offerhaus G, Traboulsi E, et al. Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis. Gut. 1991;32(10):1170–1174. Baba S, Tsuchiya M, Watanabe I, Machida H. Importance of retinal pigmentation as a subclinical marker in familial adenomatous polyposis. Dis Colon Rectum. 1990;33(8):660–664. Polkinghorne P, Ritchie S, Neale K, Schoeppner G, Thomson J, Jay B. Pigmented lesions of the retinal pigment epithelium and familial adenomatous polyposis. Eye (Lond). 1990;4:216–221. Iwama T, Mishima Y, Okamoto N, Inoue J. Association of congenital hypertrophy of the retinal pigment epithelium with familial adenomatous polyposis. Br J Surg. 1990;77(3):273–276. Heyen F, Jagelman D, Romania A, et al. Predictive value of congenital hypertrophy of the retinal pigment epithelium as a clinical marker for familial adenomatous polyposis. Colon Rectum. 1990;33:1003–1008. Chapman P, Church W, Burn J, Gunn A. Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis. BMJ. 1989;298(6670):353–354. Berk T, Cohen Z, Mcleod RS, Parker JA. Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis. Dis Colon Rectum. 1988;31(4):253–257.